|
1PZL
Crystal structure of HNF4a LBD in complex with the ligand and the coactivator SRC-1 peptide
Deposited 2003-07-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
133–369(237 aa)
Fragment:HNF4A-LDB
|
Mutation:D137L, S138A
|
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;294 K;Sodium, Potassium Tartrate, Hepes, DTT, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 2.10 Å
R-free 0.267
|
|
3FS1
Crystal structure of HNF4a LBD in complex with the ligand and the coactivator PGC-1a fragment
Deposited 2009-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
148–377(230 aa)
Fragment:HNF4a Ligand Binding Domain
|
Not recorded
|
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.20 Å
R-free 0.236
|
|
4B7W
Ligand binding domain human hepatocyte nuclear factor 4alpha: Apo form
Deposited 2012-08-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
142–377(236 aa)
Fragment:LIGAND BINDING DOMAIN, RESIDUES 142-377
Chain B
142–377(236 aa)
Fragment:LIGAND BINDING DOMAIN, RESIDUES 142-377
Chain C
142–377(236 aa)
Fragment:LIGAND BINDING DOMAIN, RESIDUES 142-377
Chain D
142–377(236 aa)
Fragment:LIGAND BINDING DOMAIN, RESIDUES 142-377
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;0.7 M AMMONIUM ACETATE, 0.1 M SODIUM CITRATE, 10 MM DTT, 16% MPD IN 0.1 M TRIS, PH 8.0
|
Resolution 4.00 Å
R-free 0.280
|
|
4IQR
Multi-Domain Organization of the HNF4alpha Nuclear Receptor Complex on DNA
Deposited 2013-01-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain A
55–377(323 aa)
Fragment:unp residues 55-377
Chain B
55–377(323 aa)
Fragment:unp residues 55-377
|
Not recorded
|
MYR MYRISTIC ACID × 2
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;0.1M MES, 25mM NH4Cl, 25mM MgCl2 and PEG 3350 , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.90 Å
R-free 0.278
|
|
4IQR
Multi-Domain Organization of the HNF4alpha Nuclear Receptor Complex on DNA
Deposited 2013-01-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–DNA
Heteromer;Protein × 4
PDB declaration: hexameric
|
Chain E
55–377(323 aa)
Fragment:unp residues 55-377
Chain F
55–377(323 aa)
Fragment:unp residues 55-377
|
Not recorded
|
MYR MYRISTIC ACID × 2
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;0.1M MES, 25mM NH4Cl, 25mM MgCl2 and PEG 3350 , pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.90 Å
R-free 0.278
|
|
6CHT
HNF4alpha in complex with the corepressor EBP1 fragment
Deposited 2018-02-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 10
PDB declaration: decameric
|
Chain A
178–421(244 aa)
Chain B
178–421(244 aa)
Chain J
178–421(244 aa)
Chain K
178–421(244 aa)
Chain M
178–421(244 aa)
Chain N
178–421(244 aa)
Chain V
178–421(244 aa)
Chain W
178–421(244 aa)
|
Not recorded
|
DAO LAURIC ACID × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.25;293 K;0.1 m Bis-Tris, 26-28% MPD, 3-4% PEG8000, 20-50 mM Glycine and 10% glycerol
|
Resolution 3.17 Å
R-free 0.274
|
|
6CHT
HNF4alpha in complex with the corepressor EBP1 fragment
Deposited 2018-02-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 10
PDB declaration: decameric
|
Chain D
178–421(244 aa)
Chain E
178–421(244 aa)
Chain G
178–421(244 aa)
Chain H
178–421(244 aa)
Chain P
178–421(244 aa)
Chain Q
178–421(244 aa)
Chain S
178–421(244 aa)
Chain T
178–421(244 aa)
|
Not recorded
|
DAO LAURIC ACID × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.25;293 K;0.1 m Bis-Tris, 26-28% MPD, 3-4% PEG8000, 20-50 mM Glycine and 10% glycerol
|
Resolution 3.17 Å
R-free 0.274
|
|
8C1L
Crystal structure of HNF4 alpha LBD in complexes with palmitic acid and GRIP-1 peptide
Deposited 2022-12-20
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
148–377(230 aa)
Chain B
148–377(230 aa)
|
Not recorded
|
PLM PALMITIC ACID × 2
EDO 1,2-ETHANEDIOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;284 K;20% PEG3350 -- 10% ethylene glycol -- 0.1M bis-tris-propane pH 8.5 -- 0.2M sodium nitrate
|
Resolution 2.00 Å
R-free 0.237
|
|
9IBR
Crystal structure of HNF4 alpha LBD complexed with GRIP-1 peptide and ESY13
Deposited 2025-02-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
148–377(230 aa)
|
Not recorded
|
A1I1W 2-hydroxy-5-(phenylethynyl)benzoic acid × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;289 K;16% PEG3350
8% ethylene glycol
0.1M bis-tris-propane pH 8.5 -
|
Resolution 2.78 Å
R-free 0.355
|